Takeda Pharmaceutical
TAK
#491
Rank
โ‚น4.263 T
Marketcap
โ‚น1,281
Share price
0.28%
Change (1 day)
12.67%
Change (1 year)

Takeda Pharmaceutical (TAK) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น450.26 Billion

According to Takeda Pharmaceutical's latest financial reports the company has โ‚น450.26 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Takeda Pharmaceutical - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31โ‚น231.23 B-11.2%
2024-03-31โ‚น260.38 B-23.67%
2023-03-31โ‚น341.13 B-37.47%
2022-03-31โ‚น545.52 B-17.7%
2021-03-31โ‚น662.84 B44.78%
2020-03-31โ‚น457.82 B0.9%
2019-03-31โ‚น453.73 B97.49%
2018-03-31โ‚น229.75 B4.78%
2017-03-31โ‚น219.26 B-33.52%
2016-03-31โ‚น329.84 B-10.94%
2015-03-31โ‚น370.35 B-25.13%
2014-03-31โ‚น494.63 B52.93%
2013-03-31โ‚น323.43 B14.47%
2012-03-31โ‚น282.55 B-39.39%
2011-03-31โ‚น466.15 B11.06%
2010-03-31โ‚น419.72 B7.98%
2009-03-31โ‚น388.71 B-41.12%
2008-03-31โ‚น660.14 B0.04%
2007-03-31โ‚น659.90 B-7.25%
2006-03-31โ‚น711.52 B15.72%
2005-03-31โ‚น614.87 B11.6%
2004-03-31โ‚น550.94 B19.55%
2003-03-31โ‚น460.83 B42.01%
2002-03-31โ‚น324.50 B21.79%
2001-03-31โ‚น266.44 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
โ‚น1.672 T 271.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น941.61 B 109.12%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
โ‚น1.349 T 199.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น878.64 B 95.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
โ‚น111.44 B-75.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
โ‚น70.79 B-84.28%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
โ‚น850.90 B 88.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น400.39 B-11.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น1.640 T 264.43%๐Ÿ‡บ๐Ÿ‡ธ USA